Predictive Value of suPAR and hsCRP on Postoperative Mortality in Cardiac Surgery

CompletedOBSERVATIONAL
Enrollment

951

Participants

Timeline

Start Date

August 6, 2012

Primary Completion Date

June 11, 2019

Study Completion Date

December 16, 2019

Conditions
Thoracic SurgeryCardiac Surgical ProceduresBiomarkers
Interventions
OTHER

Blood sampling

Analysis will be performed using commercially available analyses (suPARnostic® kit (validated to measure suPAR concentrations between 0.6 and 22 ng/mL) (ViroGates)). HsCRP will be measured by high sensitivity CRP assays (Tina-quant hs-CRP latex assay (validated to measure CRP concentrations between 0.3 - 20 mg/L) (Roche/Hitachi)). In patients with CRP\>20 mg/L a regular CRP-measurement will be performed.

Trial Locations (1)

2100

Department of Cardiothoracic Anaesthesiology, Rigshospitalet, Copenhagen

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Persimune

UNKNOWN

collaborator

University of Copenhagen

OTHER

lead

Rigshospitalet, Denmark

OTHER